Evidence map›Paper›PMID 34372699›Full record

ArticlemBio2021

Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States.

Kizee A Etienne, Elizabeth L Berkow, Lalitha Gade, Natalie Nunnally, Shawn R Lockhart, Karlyn Beer, I King Jordan, Lavanya Rishishwar, Anastasia P Litvintseva

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Azole Resistance inOpen forum infectious diseases · 2026
    Article
  4. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  5. PCR Typing and Genome Sequencing of Aspergillus fumigatus.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Article
  7. Azole-ResistantJournal of fungi (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Pan-azole- and multi-fungicide-resistantApplied and environmental microbiology · 2024
    Article
  17. Article
  18. Antimicrobial agents and chemotherapy · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kizee A EtienneMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Elizabeth L BerkowMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Lalitha GadeMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Natalie NunnallyMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Karlyn BeerMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
I King JordanSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.
Lavanya RishishwarSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.
Anastasia P LitvintsevaMycotic Diseases Branch, Centers for Disease Control and Preventiongrid.416738.f, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USGeorgia Institute of Technology · US

Funding

IHRC-Georgia Tech Applied Biotechnology Laboratory
6 · The paper itself

Abstract

Azole resistance in pathogenic Aspergillus fumigatus has become a global public health issue threatening the use of medical azoles. The environmentally occurring resistance mutations, TR

Indexed as

Antifungal AgentsAspergillosisAspergillus fumigatusCytochrome P-450 Enzyme SystemDrug Resistance, FungalFungal ProteinsGenome, FungalHumansMicrobial Sensitivity TestsPolymorphism, Single NucleotideTriazolesUnited StatesWhole Genome SequencingAntifungal Agentscytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemFungal ProteinsTriazolesAspergillus fumigatusazole resistancedrug resistance mechanismspopulation geneticspopulation genomicspopulation structureTR34/L98Hwhole-genome sequencing

Identifiers

PMID34372699
PMCPMC8406307
OpenAlexW3189890289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.